Inventor · disambiguated record
Rodolfo J. Chaparro
Also filed as: CHAPARRO RODOLFO · CHAPARRO RODOLFO J
33 granted patents·67 pending applications·323 citations·filing 2015–2025
98Inventor score
Files withCUE BIOPHARMA INC90ALBERT EINSTEIN COLLEGE MEDICINE4ALBERT EINSTEIN COLLEGE MEDICINE INC3CROSSLINK THERAPEUTICS INC3
Top patents by PatentIndex Score
100 records- 0198US11905320B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Feb 20, 2024·5 cites·30 claims
- 0298US11851467B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 26, 2023·9 cites·20 claims
- 0398US11767355B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2022·Granted Sep 26, 2023·13 cites·28 claims
- 0498US11739133B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Aug 29, 2023·12 cites·30 claims
- 0598US11708400B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Jul 25, 2023·15 cites·14 claims
- 0698US11530248B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 20, 2022·14 cites·24 claims
- 0798US11505588B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Nov 22, 2022·15 cites·26 claims
- 0898US11479595B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2020·Granted Oct 25, 2022·19 cites·19 claims
- 0998US11401314B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Aug 2, 2022·17 cites·16 claims
- 1098US11377478B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Jul 5, 2022·25 cites·18 claims
- 1198US11370821B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Granted Jun 28, 2022·20 cites·21 claims
- 1298US11117945B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Granted Sep 14, 2021·28 cites·30 claims
- 1398US11104712B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2021·Granted Aug 31, 2021·19 cites·14 claims
- 1498US10927161B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·33 cites·16 claims
- 1598US10927158B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·36 cites·16 claims
- 1697US12180258B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Dec 31, 2024·1 cites·30 claims
- 1797US12152061B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Nov 26, 2024·1 cites·20 claims
- 1897US12145973B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·1 cites·20 claims
- 1997US11987610B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted May 21, 2024·1 cites·15 claims
- 2097US11702461B2T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptidesCUE BIOPHARMA INC·Filed 2020·Granted Jul 18, 2023·9 cites·18 claims
- 2196US11878062B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Jan 23, 2024·9 cites·4 claims
- 2296US11505591B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2017·Granted Nov 22, 2022·14 cites·17 claims
- 2395US11692018B2TGF-β polypeptidesCUE BIOPHARMA INC·Filed 2022·Granted Jul 4, 2023·2 cites·23 claims
- 2494US12029782B2MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Jul 9, 2024·1 cites·2 claims
- 2594US2025092110A1T-Cell Modulatory Multimeric Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2693US12006348B2T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Jun 11, 2024·3 cites·8 claims
- 2793US2025145685A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2892US11958893B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2021·Granted Apr 16, 2024·1 cites·16 claims
- 2991US2025136660A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3090US2024166719A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3189US11993641B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2023·Granted May 28, 2024·0 cites·19 claims
- 3286US12257311B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Mar 25, 2025·0 cites·33 claims
- 3385US12485184B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Dec 2, 2025·0 cites·1 claims
- 3484US2025002556A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3584US2025206794A1TGF-Beta PolypeptidesCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3682US12485183B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 2, 2025·0 cites·1 claims
- 3782US2025092113A1Multimeric T-Cell Modulatory Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3881US2022064247A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3980US12421287B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2025·Granted Sep 23, 2025·0 cites·21 claims
- 4080US2024025964A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4180US2024299515A1Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4278US2024368245A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4378US2024409606A1T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4478US2025120996A1T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4577US2025074960A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4676US2024376177A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4776US2020207824A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4875US12180297B2ATP-dependent agonists of immune cells function as anticancer agentsCROSSLINK THERAPEUTICS INC·Filed 2024·Granted Dec 31, 2024·0 cites·27 claims
- 4975US2023321206A1Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 5073US2019352363A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rodolfo J. Chaparro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →